Scientific Program
Complete Program
(PDF format)
SCIENTIFIC PROGRAM
PICS ~ AICS 2010 Program
Sunday, July 18, 2010
6:30AM-6:00PM REGISTRATION - SHERATON PROMENADE LEVEL 4
SPEAKER READY ROOM - COLUMBUS LOBBY LEVEL 3
6:30-7:45AM Continental Breakfast - SHERATON PROMENADE LEVEL 4
8:00AM-12:30PM Workshop: Atrial Septal Defects/PFO's - SHERATON BALLROOM LVL 4
Moderators: Thomas Jones, Mario Carminati & Bagrat Alekyan
8:05-8:15AM 1. Pathological Correlation: Paul Weinberg
8:15-8:25AM 2. Echocardiography of the Atrial Septum: Craig Fleishman
8:25-8:35AM 3. Historical Perspectives on ASD Closure: Terry King
8:35-8:45AM 4. How To Start A Successful Program of Atrial Closure. Proctoring, Stocking the Cath Lab, etc: Ted Feldman
8:45-8:55AM 5. How To Close Simple ASDs: Choice of Devices:Geoffrey Lane
8:55-9:05AM 6. How To Close Large and Complex ASDs, Including Multiple ASDs:
Zahid Amin
9:05-9:15AM 7. ASD's With Pulmonary Hypertension: Evaluation and Assessing Closability: Carlos Zabal
9:15-9:25AM 8. Long-term Outcome of ASD Closure: John Bass
9:25-9:35AM 9. New Minimally Invasive Surgical Techniques: Pedro del Nido
10. Debate#1: Surgery vs Device Closure of ASDs in Small Infants & Children
9:35-9:45AM A. Pro Device: David Balzer
9:45-9:55AM B. Pro Surgery: Emile Bacha
9:55-10:05AM Rebuttal & Questions
10:00-10:30AM Coffee Available - SHERATON PROMENADE LEVEL 4
10:05-10:15AM 11. PFO's & Stroke: Where are we with the trials? John Rhodes
10:15-10:25AM 12. PFO & Migraines: Where are we with the trials? Jon Tobis
10:25-10:35AM 13. How to enroll patients in clinical trials? Where do you get the patients from? Sherm Sorensen
10:35-10:45AM 14. Complications Of Device Closure of the Atrial Defects:
How common, what do we need to fear? How to minimize them?
Horst Sievert
10:45-10:55AM 15. Metallurgy, Biodegradable, Bioabsorbable Devices: Carol Devellian
16. Devices for ASD & PFO Closure
11:00-11:06AM A. Amplatzer Devices: Alpay Celiker
11:06-11:12AM B. Helex Devices: Tom Jones
11:12-11:18AM C. Occlutech Devices: Ali El-Halabi
11:18-11:24AM D. Solysafe Device: Peter Ewert
11:24-11:30AM E. pfm device: Miguel Granja
11:30-11:36AM F. Coherex Flat Stent: Olaf Franzen
11:36-11:42AM G. Cardia Devices: Tom Forbes
11:42-11:48AM H. Patch Closure of Defects: Terry Sideris
11:48-11:54AM I. NMT Devices: Lee Benson
11:54AM-12:00PM J. The Premere Device: John Rhodes
12:00-12:10PM 17. Retrieval of embolized devices: John Moore
12:20-12:40PM Update On The IMPACT Registry
Gerard Martin
12:40PM Lunch Available - SHERATON PROMENADE LEVEL 4
1:15-2:15PM AGA Workshop - SHERATON BALLROOM LEVEL 4
Advanced ASD Closure Featuring the AMPLATZER Septal Occluder
1:15-1:40PM A Review Of My Complex ASD Cases: David Balzer
1:40-2:05PM ASD Device Tips & Tricks; Greatest Challenges for Implanting MDs: Frank Ing
2:05-2:15PM Q&A
1:00-2:00PM CCISC Meeting - CHICAGO BALLROOM 8 LEVEL 4
Chair: Tom Forbes
2:00-3:00PM SCAI Meeting - CHICAGO BALLROOM 9 LEVEL 4
Chair: Don Hagler
3:00-4:00PM Meet The Expert (three rooms)
Room 1-Moderators: Michael Tynan, Zahid Amin & John Moore
CHICAGO BALLROOM 8 LEVEL 4
Room 2-Moderators: Charles Mullins, Evan Zahn, Phillip Moore
CHICAGO BALLROOM 9 LEVEL 4
Room 3-Moderators: William E. Hellenbrand, John P. Cheatham,
JV De Giovanni
CHICAGO BALLROOM 10 LEVEL 4
4:00-6:00PM Oral Abstract Presentations (three rooms)
_____________________________________________
Room 1: CHICAGO BALLROOM 8 LEVEL 4
Moderators: Teiji Akagi, Mazeni Alwi & David Balzer
4:00:00 - 4:08:30PM |
|
BALLOON PULMONARY VALVULOPLASTY: PROSPECTIVE ANALYSIS OF PROCEDURE-RELATED ADVERSE EVENTS AND IMMEDIATE OUTCOME - RESULTS FROM A MULTICENTER REGISTRY (C3PO) |
|
|
|
4:08:30 - 4:17:00PM |
|
ADVERSE EVENTS ASSOCIATED WITH PULMONARY ARTERY REHABILITATION - A PROSPECTIVE MULTICENTER EXPERIENCE (C3PO) |
|
|
|
4:17:00 - 4:25:30PM |
|
ATRIAL SEPTAL INTERVENTIONS IN INFANTS AFTER DUCTAL STENTING AND BILATERAL PULMONARY ARTERY BANDING |
|
|
|
4:25:30 - 4:34:00PM |
|
APPLICATION OF CARDIO-O - FIX OCCLUDERS FOR TRANSCATHETER PERCUTANEOUS CLOSURE OF ATRIAL SEPTAL DEFECTS TYPE II (ASD), PATENT FORAMEN OVALE (PFO) AND PATENT DUCTUS ARTERIOSUS (PDA) - PRELIMINARY EXPERIENCE . |
|
|
|
4:34:00 - 4:42:30PM |
|
ABSTRACT WITHDRAWN |
|
|
|
4:42:30 - 4:51:00PM |
|
MODIFIED EXPOSURE SETTINGS AND DOSE-DEPENDENT FOLLOW-UP PROTOCOLS LEAD TO IMPROVED PICK-UP OF PATIENTS WITH RADIATION BURNS AND LOWER PATIENT EXPOSURE |
|
|
|
4:51:00 - 4:59:30PM |
|
EXPERIENCE WITH THE AMPLATZER VASCULAR PLUG II TO OCCLUDE DIFFERENT TYPES OF PATENT DUCTUS ARTERIOSUS IN PEDIATRIC PATIENTS. |
|
|
|
4:59:30 - 5:08:00PM |
|
THE USE OF PRESSURE WIRES TO EVALUATE CONGENITAL AND STRUCTURAL HEART DISEASE |
|
|
|
5:08:00 - 5:16:30PM |
|
ANTEROGRADE STENT IMPLANTATION FOR THE TREATMENT OF RECURRENT COARCTATION AFTER NORWOOD OPERATION. |
|
|
|
5:16:30 - 5:25:00PM |
|
IMPLANTATION OF STENTS FOR TREATMENT OF RECURRENT AND NATIVE COARCTATION IN CHILDREN WEIGHING LESS THAN 20 KILOGRAMS. |
|
|
|
5:25:00 - 5:33:30PM |
|
5 TO 16 YEAR OUTCOMES OF TRANSCATHETER AND SURGICAL ASD CLOSURE: DATA FROM A SINGLE CENTER. |
|
|
|
5:33:30 - 5:42:00PM |
|
LATE PERCUTANEOUS RETRIEVAL OF AMPLATZER DEVICES. |
|
|
|
5:42:00 - 5:50:30PM |
|
PERCUTANEOUS DEVICE CLOSURE OF CONGENITAL & IATROGENIC VENTRICULAR SEPTAL DEFECTS IN THE ADULT PATIENTS |
|
|
|
5:50:30 - 5:59:00PM |
|
RESULTS OF TRANSCATHETER PULMONARY VALVE IMPLANTATION USING THE EDWARDS SAPIEN THV: US FEASABILITY (COMPASSION) RESULTS. |
_____________________________________________
Room 2: CHICAGO BALLROOM 9 LEVEL 4
Moderators: Carlos Zabal, John Bass & Philipp Bonhoeffer
4:00:00 - 4:08:30PM |
|
PERCUTANEOUS CLOUSURE OF 150 PERIMEMBRANOUS VSD, WITH NO LONG TERM COMPICATIONS. |
|
|
|
4:08:30 - 4:17:00PM |
|
FIRST EXPERIENCES WITH USING ANDRASTENTS IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE - SINGLE CENTRE EXPERIENCE |
|
|
|
4:17:00 - 4:25:30PM |
|
USEFULNESS OF BALLOON ANGIOPLASTY FOR THE RV-PA SHUNT WITH THE MODIFIED NORWOOD PROCEDURE |
|
|
|
4:25:30 - 4:34:00PM |
|
PERSISTENT PROXIMAL HYPERTENSION(PHBP) IN POST COA - ROLE OF THE HYPOPLASTIC ARCH(HA) |
|
|
|
4:34:00 - 4:42:30PM |
|
PALLIATIVE STENTING OF PATENT DUCTUS ARTERIOSUS IN CHILDREN AND ADULTS WITH CYANOTIC HEART DISEASE |
|
|
|
4:42:30 - 4:51:00PM |
|
ANGIOGRAPHIC INDICES THAT PREDICT INTERVENTION FOR RECURRENT AORTIC ARCH STENOSIS FOLLOWING NORWOOD ARCH RECONSTRUCTION |
|
|
|
4:51:00 - 4:59:30PM |
|
IMMEDIATE AND LONG TERM RESULTS FROM BALLOON VALVOPLASTY FOR CRITICAL CONGENITAL AORTIC STENOSIS: A 16 YEAR EXPERIENCE OF A SINGLE TERTIARY CARDIAC CENTER |
|
|
|
4:59:30 - 5:08:00PM |
|
INCIDENCE OF POST-CARDIAC CATHETERIZATION RENAL FUNCTION ABNORMALITIES IN PEDIATRIC ICU PATIENTS |
|
|
|
5:08:00 - 5:16:30PM |
|
PAVSD MAPCAS: DOES AN AGGRESSIVE INTERVENTIONAL APPROACH IMPROVE THE OUTCOME? |
|
|
|
5:16:30 - 5:25:00PM |
|
COMBINED CUTTING BALLOON AND HIGH PRESSURE BALLOON ANGIOPLASTY IN DOGS WITH SEVERE SUBAORTIC STENOSIS IS EFFECTIVE AT MID-TERM FOLLOW-UP. |
|
|
|
5:25:00 - 5:33:30PM |
|
STENTING OF NATIVE AND RE-COARCTATION WITH A NEW CHROMIUM-COBALT STENT (ANDRA STENTR) IN CHILDREN AND YOUNG ADULTS |
|
|
|
5:33:30 - 5:42:00PM |
|
ARTERIAL DUCT STENTING IN LOW-WEIGHT NEWBORNS (<2.5 KGS) WITH CONGENITAL HEART DISEASE AND DUCT-DEPENDENT PULMONARY CIRCULATION |
|
|
|
5:42:00 - 5:50:30PM |
|
EFFICACY AND SAFETY OF DEVICE CLOSURE OF PULMONARY HYPERTENSIVE PDA'S IN INTERMEDIATE AND LONG TERM |
|
|
|
_____________________________________________
Room 3: CHICAGO BALLROOM 10 LEVEL 4
Moderators: Lee Benson, Mario Carminati & Dietmar Schranz
4:00:00 - 4:08:30PM |
|
MIDTERM OUTCOMES IN PATIENTS WITH ATRIAL SEPTAL DEFECT AND PULMONARY HYPERTENSION TREATED WITH AMPLAZTER SEPTAL OCCLUDER |
|
|
|
4:08:30 - 4:17:00PM |
|
OUTCOME OF BALLOON ANGIOPLASTY OF RE-COARCTATION OF THE NEOAORTIC ARCH AFTER THE NORWOOD OPERATION: A SINGLE CENTER EXPERIENCE. |
|
|
|
4:17:00 - 4:25:30PM |
|
INTERMEDIATE -TERM EFFECTS OF TRANSCATHETER CLOSURE OF SECUNDUM ATRIAL SEPTAL DEFECT ON CARDIAC REMODELING IN CHILDREN AND ADULTS |
|
|
|
4:25:30 - 4:34:00PM |
|
CHALLENGES OF MANAGING INFERIOR VENACAVAL OBSTRUCTION BY CAUDATE LOBE ENLARGEMENT |
|
|
|
4:34:00 - 4:42:30PM |
|
TRANSCATHETER CLOSURE OF LARGE PDA IN INFANTS ≤ 6 kgs WITH DUCT OCCLUDER |
|
|
|
4:42:30 - 4:51:00PM |
|
RENAL ARTERY STENOSIS IN CHILDREN: THERAPEUTIC PERCUTANEOUS BALLOON AND STENT ANGIOPLASTY |
|
|
|
4:51:00 - 4:59:30PM |
|
PERVENTRICULAR DEVICE CLOSURE IN INFANTS-OUR INITIAL EXPERIENCE |
|
|
|
4:59:30 - 5:08:00PM |
|
EARLY ITALIAN EXPERIENCE OF IN-TUNNEL PFO CLOSURE WITH COHEREX FLATSTENTT EF |
|
|
|
5:08:00 - 5:16:30PM |
|
HYBRID STAGE I PALLIATION IN HIGH RISK NEONATES MAY IMPROVE SURVIVAL TO DISCHARGE COMPARED TO NORWOOD PALLIATION |
|
|
|
5:16:30 - 5:25:00PM |
|
ASPIRIN NON-RESPONSIVENESS, GENETIC POLYMORPHISMS IN PLATELET AGGREGATION, AND THE RISK OF THROMBUS FORMATION IN CHILDREN WITH CONGENITAL HEART DISEASE |
|
|
|
5:25:00 - 5:33:30PM |
|
COMPARISON OF PERCUTANEOUS CLOSURE OF SMALL PATENT DUCTUS ARTERIOSUS BY DETACHABLE COILS VERSUS THE NEW AMPLATZER DUCT OCCLUDER DEVICE |
|
|
|
5:33:30 - 5:42:00PM |
|
ATRIAL SEPTAL DEFECT DEVICES: DO WE NEED FOUR BRANDS IN OUR CATH LAB? |
|
|
|
5:42:00 - 5:50:30PM |
|
A FULLY INTEGRATED, READY-TO-USE, LOW-PROFILE, DRY MEMBRANE PERCUTANEOUS HEART VALVE SYSTEM FOR THE AORTIC AND PULMONARY POSITIONS |
|
|
David Fish (O-40) |
6:00-8:00PM Welcome Reception in Exhibit Hall
CHICAGO BALLROOM 6 & 7 LEVEL 4
Exhibits Open